Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335510 · ClinicalTrials.gov registry record · NA
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
A NA study, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT07335510 is a NA study that is actively recruiting participants, run by Columbia University. The registered enrollment target is 58 participants.
The verdict
NCT07335510, a NA study, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to assess how therapy using this device affects heart function, symptoms, and exercise capacity, with particular focus on how the device affects blood flow and heart pressures during exercise. Information from this study may help inform patient selection and device management in patients with heart failure.
Interventions
- DEVICE Baroreflex Activation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335510
The ClinicalTrials.gov registry entry for NCT07335510 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baroreflex Activation Therapy is the first listed.
NCT07335510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07335510 about?
NCT07335510 is a clinical study titled "Impact of Barostimulation on Hemodynamics in Adults With Heart Failure". This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to assess how therapy usi...
What is the current status of trial NCT07335510?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2026-03-30. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07335510?
The interventions under investigation include: Baroreflex Activation Therapy (DEVICE).
Who is sponsoring clinical trial NCT07335510?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.